Panel
Janet Hemingway is Professor of Tropical Medicine at the Liverpool School of Tropical Medicine (LSTM) and Founding Director of the Infection Innovation Consortium (iiCON). Responding to the growing challenge of infectious diseases, antimicrobial resistance, and emerging pandemics, iiCON brings together academic, industry, and clinical partners in a £170 million programme to transform the discovery and supply of much-needed anti-infectives and accelerate their journey to market.
She is a senior technical advisor on Neglected Tropical Diseases for the Bill and Melinda Gates Foundation and has been PI on projects in excess of £370 million including the BMGF funded Innovative Vector Control Consortium, the ERDF funded Formulations programme and the BMGF funded Visceral Leishmaniasis Elimination programme.
She is a Past President of the Royal Society of Tropical Medicine and Hygiene.
Professor Hemingway was appointed the Director of LSTM in 2001 and stepped down on 1st January 2019. She was awarded a CBE for services to the Control of Tropical Disease Vectors in 2012.
Nige joined CSL Seqirus in January 2019 with 30 years Pharma experience gained in Site Operations, engineering, product development and industrialisation.
Nige spent his early career working for AstraZeneca delivering production plant expansion and routine operations for a sterile parental product, Zoladex. He then joined Sanofi’s inhalation development and manufacturing site where he held positions as Head of Device development, Head of Engineering and Head of Manufacturing Operations. During this time, he played a major role in shaping strategy, restructuring the business and delivering a site turnaround. This included leading the successful industrialisation and routine supply of third-party products as part of a transition to becoming a CMO under new ownership.
Nige is a chartered Engineer and holds a Bachelor of Science degree in Mechanical Engineering. He is a formally trained six sigma black belt and experienced lean practitioner.
Prior to joining The Pandemic Institute, Caryn was Manager of the Doctoral Training Hub at the University of Glasgow, leading a multi-institutional team responsible for providing end-to-end management and administration for numerous UKRI-funded Centres for Doctoral Training (CDTs). At this time, Caryn also served as Coordinator for the CDT in Future Ultrasonic Engineering in partnership with Strathclyde University. Before this, Caryn worked as a Business Development Manager for an EPSRC and SFI CDT between the University of Glasgow, Queen’s University Belfast and the Irish Photonic Integration Centre.
Caryn’s former research background was based on spectral pathology for disease-state diagnostics, working as a PhD student and Research Associate at the Cancer Research UK Manchester Institute, the Analytical and Medical Vibrational Spectroscopy Group at the Manchester Institute of Biotechnology, and as a Visiting Researcher at the Spectral Analytics Laboratory at the University of Strathclyde.
